Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive med
| Current Price | ₹375.75 |
|---|---|
| Market Cap | ₹3,445 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 18.8 |
| Return on Equity | 27.47% |
| 52-Week Range | ₹342.00 – ₹640.85 |
| Beta (1Y) | 0.77 |
| Dividend Yield | 1.06% |
1. Healthcare-100%
Indraprastha Medical Corporation Limited (Indramedco) is trading at ₹375.75, with a market capitalisation of ₹3,445 Cr.
Indraprastha Medical Corporation Limited (Indramedco) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Indraprastha Medical Corporation Limited (Indramedco) has a P/E of 18.8 and a return on equity of 27.47%.